Search results for "VTE"
Pinpoint PE in high-risk patients with syncope
The evidence on the prevalence of pulmonary embolism (PE) among patients with syncope has been mixed.
https://acphospitalist.acponline.org/archives/2018/12/pinpoint-pe-in-syncope.htm
15 Dec 2018
Updated guideline issued on antithrombotic therapy for VTE
The American College of Chest Physicians issued an updated guideline last week on antithrombotic therapy for venous thromboembolism (VTE), covering topics such as use of direct-acting oral anticoagulants and outpatient treatment of pulmonary embolism.
https://acphospitalist.acponline.org/weekly/archives/2016/01/13/1.htm
13 Jan 2016
Prophylaxis after discharge doesn't reduce VTE rates in high-risk patients
Venous thromboembolism (VTE) prophylaxis in high-risk medical service patients didn't reduce rates of symptomatic VTE in the 90 days after hospital discharge, a study found.
https://acphospitalist.acponline.org/weekly/archives/2011/12/14/3.htm
14 Dec 2011
August 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/08/
Unfractionated heparin may be underprescribed in obese patients with VTE
Obese patients may not receive correct weight-based doses of unfractionated heparin for venous thromboembolism (VTE), according to a new single-site study.
https://acphospitalist.acponline.org/weekly/archives/2011/04/27/5.htm
27 Apr 2011
Infection, other factors may increase risk for VTE hospitalization
Infection, treatment with erythropoiesis-stimulating agents, and blood transfusion may increase risk for hospitalization due to venous thromboembolism (VTE), according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/2.htm
11 Apr 2012
January 2012
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2012/01/
For inpatient VTE prevention, rivaroxaban noninferior to enoxaparin
Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2013/02/13/3.htm
13 Feb 2013
January 2015
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2015/01/
Oral anticoagulants compared for risk of recurrent VTE, major bleeds
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/09/11/4.htm
11 Sep 2013